Repligen reported 138.54 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Agilent 23.66 3.13 Jun/2026
Align Technology 17.17 4.64 Sep/2026
Bio Techne 62.47 10.33 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
Bruker 53.51 6.97 Sep/2026
Charles River Laboratories 27.69 30.58 Sep/2026
Danaher 35.77 3.09 Sep/2026
Dentsply International 16.45 3.86 Sep/2026
General Electric Aerospace 34.61 8.47 Sep/2026
Henry Schein 21.59 2.45 Sep/2026
Illumina 70.8 21.82 Sep/2026
IQVIA Holdings 29.03 7.58 Sep/2026
Mettler Toledo International 27.29 0.04 Jun/2026
OraSure Technologies 24.42 12.6 Sep/2024
Pfizer 15.2 3.72 Sep/2026
Repligen 138.54 33.44 Sep/2026
Revvity 56.86 20.39 Sep/2026
Thermo Fisher Scientific 35.46 9.05 Sep/2026
Waters 95.42 28.73 Sep/2026
West Pharmaceutical Services 40.64 1.99 Sep/2026